Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma

Front Immunol. 2023 Jan 25:14:1083069. doi: 10.3389/fimmu.2023.1083069. eCollection 2023.

Abstract

Liver cancer is one of the most common malignant tumors globally. Not only is it difficult to diagnose, but treatments are scarce and the prognosis is generally poor. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Aggressive cancer cells, such as those found in HCC, undergo extensive metabolic rewiring as tumorigenesis, the unique feature, ultimately causes adaptation to the neoplastic microenvironment. Intratumoral heterogeneity (ITH) is defined as the presence of distinct genetic features and different phenotypes in the same tumoral region. ITH, a property unique to malignant cancers, results in differences in many different features of tumors, including, but not limited to, tumor growth and resistance to chemotherapy, which in turn is partly responsible for metabolic reprogramming. Moreover, the different metabolic phenotypes might also activate the immune response to varying degrees and help tumor cells escape detection by the immune system. In this review, we summarize the reprogramming of glucose metabolism and tumoral heterogeneity and their associations that occur in HCC, to obtain a better understanding of the mechanisms of HCC oncogenesis.

Keywords: hepatocellular carcinoma; immune response; intratumoral heterogeneity; metabolic rearrangements; tumor microenvironment.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Cell Transformation, Neoplastic
  • Humans
  • Immunity
  • Liver Neoplasms* / pathology
  • Prognosis
  • Tumor Microenvironment / physiology